SGLT2 inhibitors, but not GLP-1 receptor agonists, reduce incidence of gout in people living with type 2 diabetes across the therapeutic spectrum
Blood samples of these patients were collected at baseline, week 4, week 12, and week 26
Among those who had bariatric surgery, that risk declined by 22% over 10 years compared to those who received no treatment
Korean Red Ginseng Protects Oxidative Injury Caused by Lead Poisoning
- Suitable for: Adults seeking maximum glutathione brightening globally
March 3rd, 2026: Federal Judge Appoints Leadership for GLP1 Vision Loss Lawsuits Multiple lawsuits alleging vision loss from GLP1 drugs, including Ozempic, Wegovy, and Mounjaro have been consolidated into a multidistrict litigation in the Eastern District of Pennsylvania, the same court responsible for handling GLP-1 lawsuits involving gastrointestinal injuries